ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
stockrock
|
1.0K |
399K |
42 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
stockrock
|
1.0K |
399K |
77 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
77
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
stockrock
|
1.0K |
399K |
81 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
399K
|
81
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Business Update for Q2 2023
|
|
stockrock
|
15 |
6.9K |
6 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
15
|
6.9K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stockrock
|
17K |
6.7M |
56 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
17K
|
6.7M
|
56
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stockrock
|
17K |
6.7M |
18 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
17K
|
6.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
stockrock
|
3.4K |
1.2M |
128 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
128
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
stockrock
|
3.4K |
1.2M |
42 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
stockrock
|
3.4K |
1.2M |
38 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
38
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
stockrock
|
3.4K |
1.2M |
114 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
114
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma CEO to retire in 2024
|
|
stockrock
|
69 |
26K |
5 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
69
|
26K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
stockrock
|
55 |
22K |
48 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
55
|
22K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
stockrock
|
9.8K |
2.9M |
18 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
9.8K
|
2.9M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
stockrock
|
3.4K |
1.2M |
46 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
46
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
stockrock
|
232 |
67K |
22 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
232
|
67K
|
22
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
stockrock
|
232 |
67K |
29 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
232
|
67K
|
29
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
stockrock
|
232 |
67K |
39 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
232
|
67K
|
39
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
stockrock
|
232 |
67K |
22 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
232
|
67K
|
22
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Equity Raising Investor Presentation
|
|
stockrock
|
302 |
121K |
27 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
302
|
121K
|
27
|
|
ASX - By Stock
|
TIE |
Re:
TIE recommendation!
|
|
stockrock
|
107 |
37K |
4 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
107
|
37K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Equity Raising Investor Presentation
|
|
stockrock
|
302 |
121K |
62 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
302
|
121K
|
62
|
|
ASX - By Stock
|
TIE |
Re:
TIE recommendation!
|
|
stockrock
|
107 |
37K |
9 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
107
|
37K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Equity Raising Investor Presentation
|
|
stockrock
|
302 |
121K |
36 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
302
|
121K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
stockrock
|
1.0K |
391K |
66 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
stockrock
|
1.0K |
391K |
78 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
78
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Second Quarter Financial Results Webcast
|
|
stockrock
|
56 |
18K |
9 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
56
|
18K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Second Quarter Financial Results Webcast
|
|
stockrock
|
56 |
18K |
24 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
56
|
18K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
stockrock
|
1.0K |
391K |
14 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
stockrock
|
1.0K |
391K |
92 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
92
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
stockrock
|
74 |
28K |
9 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
stockrock
|
74 |
28K |
4 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
stockrock
|
74 |
28K |
15 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
stockrock
|
901 |
283K |
19 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
901
|
283K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
stockrock
|
901 |
283K |
11 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
901
|
283K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
stockrock
|
901 |
283K |
29 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
901
|
283K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
stockrock
|
901 |
283K |
42 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
901
|
283K
|
42
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
stockrock
|
618 |
237K |
32 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
618
|
237K
|
32
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
stockrock
|
618 |
237K |
57 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
618
|
237K
|
57
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
stockrock
|
618 |
237K |
63 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
618
|
237K
|
63
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
stockrock
|
914 |
290K |
16 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
914
|
290K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
stockrock
|
914 |
290K |
67 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
914
|
290K
|
67
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
stockrock
|
914 |
290K |
84 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
914
|
290K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
stockrock
|
914 |
290K |
59 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
914
|
290K
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
stockrock
|
914 |
290K |
62 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
914
|
290K
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
stockrock
|
914 |
290K |
48 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
914
|
290K
|
48
|
|
ASX - By Stock
|
FLC |
Re:
US and Caribbean
|
|
stockrock
|
34 |
14K |
8 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
34
|
14K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Biotech Showcase 2023 Presentation in San Francisco
|
|
stockrock
|
179 |
69K |
45 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
179
|
69K
|
45
|
|
ASX - By Stock
|
FLC |
Re:
US and Caribbean
|
|
stockrock
|
34 |
14K |
10 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
34
|
14K
|
10
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Amended Weblink - Investor Presentation & Update 5 Dec 2022
|
|
stockrock
|
47 |
18K |
7 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
47
|
18K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Completion of $30m Institutional Placement
|
|
stockrock
|
181 |
55K |
4 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
181
|
55K
|
4
|
|